Top Industry Leaders in the Antiandrogens Market
Latest Antiandrogens Companies Update:
Pfizer, a leading player in the market, is actively developing next-generation antiandrogens like ODM-201 with improved efficacy and tolerability profiles.
Astellas Pharma has secured regulatory approval for Xtandi (enzalutamide) in Japan, expanding its reach in the Asia-Pacific market.
Approval of Erleada (apalutamide) by the FDA for the treatment of non-metastatic castration-resistant prostate cancer marks a significant advancement in early-stage intervention. Development of next-generation antiandrogens with improved efficacy and reduced side effects is an ongoing focus in research and development.
List of Antiandrogens Key companies in the market
-
Pfizer Inc.
-
Astellas Pharma Inc.
-
F. Hoffmann-La Roche Ltd.
-
AstraZeneca Plc
-
Abbott Laboratories
-
Takeda Pharmaceutical Company Limited
-
OSI Pharmaceuticals, Inc.
-
Genentech Inc.
-
Bristol-Myers Squibb Company
-
Novartis AG
-
Progenics Pharmaceuticals, Inc.,
-
ALZA Corporation
-
Sanofi SA
-
GlaxoSmithKline Plc
-
Amgen Inc
-
ANI Pharmaceuticals, Inc.